The impact of market volatility on the cell therapy industry.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 22056137.
- Also identified by DOI 10.1016/j.stem.2011.10.010.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Stock market volatility in the cell therapy industry has greatly hindered the investment necessary to fund translational therapies. Here, we review the volatility of leading companies and suggest that a distinct industry is maturing to a point at which the volatility should subside, providing a more attractive environment for future growth.
Medical subject headings
- Drug Industry
- Marketing
- Stem Cell Transplantation